Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05492786 · ClinicalTrials.gov registry record · NA
High-risk Influenza Vaccine Alert
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 80,452
- Enrollment target
NCT05492786: Completed NA study, sponsored by Geisinger Clinic.
NCT05492786 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 80,452 participants, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (5638% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05492786, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 80,452 participants
- Enrollment target
Study Summary
The purpose of this study is to assess, prospectively, the effect on flu vaccination rates of salient alerts in the electronic health record that indicate a patient's high risk for flu and its complications. The investigators hypothesize that the salient alerts will lead to increased flu vaccination compared with a standard flu alert.
Primary Outcome
Patient received a flu vaccine (yes/no)
Interventions
- BEHAVIORAL Alert
- BEHAVIORAL Salient alert features
- BEHAVIORAL High-risk Text
- BEHAVIORAL Risk factors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80,452 participants |
| Start Date | 2022-09-01 |
| Est. Completion | 2023-04-01 |
| Phase | NA |
What the finished NCT05492786 record still lists
NCT05492786 is an interventional study that assigns participants to a tested intervention. Its 80,452 participants enrollment target places it among the larger protocols in the corpus, above the 1,402-participant average among 58,714 other NA trials with a reported enrollment target (5638% higher).
The record links to 0 conditions, and to 4 interventions - of which Alert is the first listed.
NCT05492786 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05492786 about?
NCT05492786 is a clinical study titled "High-risk Influenza Vaccine Alert". The purpose of this study is to assess, prospectively, the effect on flu vaccination rates of salient alerts in the electronic health record that indicate a patient's high risk for flu and its complications. The investigators hypothesize that the salient alerts will lead to increased flu vaccination...
What is the current status of trial NCT05492786?
This trial is currently completed. It is a NA study. The enrollment target is 80,452 participants. The study started on 2022-09-01. Estimated completion is 2023-04-01.
What interventions are being tested in trial NCT05492786?
The interventions under investigation include: Alert (BEHAVIORAL), Salient alert features (BEHAVIORAL), High-risk Text (BEHAVIORAL), Risk factors (BEHAVIORAL).
Who is sponsoring clinical trial NCT05492786?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05492786's enrollment target sits among peer trials
80,452 4th of 2000 higher than 1,997 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05701111 · 80,800 participants · NA
Building Resilience at Schools: Emotional and Biological Assessment and Treatment of Traumatic Stress
- NCT00063063 · 80,000 participants
Generic Database of Very Low Birth Weight Infants
- NCT06625983 · 80,000 participants · NA
Use of a Colorectal Cancer Screening Decision Support Tool in Primary Care
- NCT02402244 · 75,000 participants
Project: Every Child for Younger Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI